These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The promise of structural genomics in the discovery of new antimicrobial agents. Buchanan SG; Sauder JM; Harris T Curr Pharm Des; 2002; 8(13):1173-88. PubMed ID: 12052226 [TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
5. When will the genomics investment pay off for antibacterial discovery? Mills SD Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281 [TBL] [Abstract][Full Text] [Related]
6. The role of genomics in antibacterial target discovery. Buysse JM Curr Med Chem; 2001 Dec; 8(14):1713-26. PubMed ID: 11562290 [TBL] [Abstract][Full Text] [Related]
7. Structural genomics of Mycobacterium tuberculosis: a preliminary report of progress at UCLA. Goulding CW; Perry LJ; Anderson D; Sawaya MR; Cascio D; Apostol MI; Chan S; Parseghian A; Wang SS; Wu Y; Cassano V; Gill HS; Eisenberg D Biophys Chem; 2003 Sep; 105(2-3):361-70. PubMed ID: 14499904 [TBL] [Abstract][Full Text] [Related]
9. Rational identification of new antibacterial drug targets that are essential for viability using a genomics-based approach. Chalker AF; Lunsford RD Pharmacol Ther; 2002 Jul; 95(1):1-20. PubMed ID: 12163125 [TBL] [Abstract][Full Text] [Related]
10. Benefits of structural genomics for drug discovery research. Grabowski M; Chruszcz M; Zimmerman MD; Kirillova O; Minor W Infect Disord Drug Targets; 2009 Nov; 9(5):459-74. PubMed ID: 19594422 [TBL] [Abstract][Full Text] [Related]
11. Harnessing the power of the genome in the search for new antibiotics. Rosamond J; Allsop A Science; 2000 Mar; 287(5460):1973-6. PubMed ID: 10720317 [TBL] [Abstract][Full Text] [Related]
12. The impact of structural proteomics on biotechnology. Manjasetty B; Turnbull A; Panjikar S Biotechnol Genet Eng Rev; 2010; 26():353-70. PubMed ID: 21415888 [TBL] [Abstract][Full Text] [Related]
13. High-throughput X-ray crystallography for drug discovery. Blundell TL; Patel S Curr Opin Pharmacol; 2004 Oct; 4(5):490-6. PubMed ID: 15351354 [TBL] [Abstract][Full Text] [Related]
14. The role of emerging genomics and proteomics technologies in cancer drug target discovery. Onyango P Curr Cancer Drug Targets; 2004 Mar; 4(2):111-24. PubMed ID: 15032664 [TBL] [Abstract][Full Text] [Related]
15. Genomics in anti-infective drug discovery--getting to endgame. Haney SA; Alksne LE; Dunman PM; Murphy E; Projan SJ Curr Pharm Des; 2002; 8(13):1099-118. PubMed ID: 12052222 [TBL] [Abstract][Full Text] [Related]